Gold nanoparticles do not induce myotube cytotoxicity but increase the susceptibility to cell death.

Gold nanoparticles (AuNP) have been widely used for many applications, including as biological carriers. A better understanding concerning AuNP safety on muscle cells is crucial, since it could be a potential tool in the nanomedicine field. Here, we describe the impact of polyethylene glycol-coated gold nanoparticles (PEG-AuNP) interaction with differentiated skeletal muscle C2C12 cells on cell viability, mitochondria function, cell signaling related to survival, cytokine levels and susceptibility to apoptosis. Intracellular localization of 4.5 nm PEG-AuNP diameter size was evidenced by STEM-in-SEM in myotube cells. Methods for cytotoxicity analysis showed that PEG-AuNP did not affect cell viability, but intracellular ATP levels and mitochondrial membrane potential increased. Phosphorylation of ERK was not altered but p-AKT levels reduced (p<0.01). Pre-treatment of cells with PEG-AuNP followed by staurosporine induction increased the caspases-3/7 activity. Indeed, cytokines analysis revealed a sharp increase of IFN-γ and TGF-β1 levels after PEG-AuNP treatment, suggesting that inflammatory and fibrotic phenotypes process were activated. These data demonstrate that PEG-AuNP affect the myotube physiology leading these cells to be more susceptible to death stimuli in the presence of staurosporine. Altogether, these results present evidence that PEG-AuNP affect the susceptibility to apoptosis of muscle cells, contributing to development of safer strategies for intramuscular delivery.

[1]  K. Baek,et al.  Enhanced cellular delivery and transfection efficiency of plasmid DNA using positively charged biocompatible colloidal gold nanoparticles. , 2007, Biochimica et biophysica acta.

[2]  Juan B. Blanco-Canosa,et al.  Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size. , 2011, ACS nano.

[3]  Sabine Neuss,et al.  Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. , 2009, Small.

[4]  Srirang Manohar,et al.  In vitro toxicity studies of polymer-coated gold nanorods , 2010, Nanotechnology.

[5]  Ying Liu,et al.  Characterization of gold nanorods in vivo by integrated analytical techniques: their uptake, retention, and chemical forms , 2010, Analytical and bioanalytical chemistry.

[6]  Navid B. Saleh,et al.  Does shape matter? Bioeffects of gold nanomaterials in a human skin cell model. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[7]  M. Berridge,et al.  Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. , 1993, Archives of biochemistry and biophysics.

[8]  B. Banfield,et al.  Localization of ERK/MAP Kinase Is Regulated by the Alphaherpesvirus Tegument Protein Us2 , 2006, Journal of Virology.

[9]  Zahi A Fayad,et al.  Multifunctional gold nanoparticles for diagnosis and therapy of disease. , 2013, Molecular pharmaceutics.

[10]  P. Gunaratne,et al.  A gold nanoparticle platform for the delivery of functional microRNAs into cancer cells. , 2013, Biomaterials.

[11]  S. Matoba,et al.  Intracellular ATP is required for mitochondrial apoptotic pathways in isolated hypoxic rat cardiac myocytes. , 2003, Cardiovascular research.

[12]  Kristen K. Comfort,et al.  Interference of silver, gold, and iron oxide nanoparticles on epidermal growth factor signal transduction in epithelial cells. , 2011, ACS nano.

[13]  Sabine Neuss,et al.  Size-dependent cytotoxicity of gold nanoparticles. , 2007, Small.

[14]  Jun Wang,et al.  Enhancement of lipopolysaccharide-induced nitric oxide and interleukin-6 production by PEGylated gold nanoparticles in RAW264.7 cells. , 2012, Nanoscale.

[15]  Haiching Ma,et al.  Cytoprotective effect of selective small-molecule caspase inhibitors against staurosporine-induced apoptosis , 2014, Drug design, development and therapy.

[16]  Hongtao Yu,et al.  Limitation of the MTT and XTT assays for measuring cell viability due to superoxide formation induced by nano-scale TiO2. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[17]  R. Shukla,et al.  Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[18]  Deny Hartono,et al.  Autophagy and oxidative stress associated with gold nanoparticles. , 2010, Biomaterials.

[19]  R. Hill,et al.  High efficacy gold-KDEL peptide-siRNA nanoconstruct-mediated transfection in C2C12 myoblasts and myotubes. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[20]  Dong Woo Kim,et al.  Gold nanoparticles attenuate LPS-induced NO production through the inhibition of NF-kappaB and IFN-beta/STAT1 pathways in RAW264.7 cells. , 2010, Nitric oxide : biology and chemistry.

[21]  L. Perkins,et al.  Nuclear Localization of the ERK MAP Kinase Mediated by Drosophila αPS2βPS Integrin and Importin-7 , 2007 .

[22]  Bong Hyun Chung,et al.  Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. , 2009, Toxicology and applied pharmacology.

[23]  Á. Villanueva,et al.  MTT assay for cell viability: Intracellular localization of the formazan product is in lipid droplets. , 2012, Acta histochemica.

[24]  Qiao Jiang,et al.  Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte. , 2010, ACS nano.

[25]  Hicham Fenniri,et al.  Widespread Nanoparticle-Assay Interference: Implications for Nanotoxicity Testing , 2014, PloS one.

[26]  Yong Li,et al.  Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. , 2004, The American journal of pathology.

[27]  B. Jarrar,et al.  Renal tissue alterations were size-dependent with smaller ones induced more effects and related with time exposure of gold nanoparticles , 2011, Lipids in Health and Disease.

[28]  S. Hsu,et al.  Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. , 2009, Small.

[29]  M. Hibner,et al.  Bupivacaine causes cytotoxicity in mouse C2C12 myoblast cells: involvement of ERK and Akt signaling pathways , 2010, Acta Pharmacologica Sinica.

[30]  M. F. Aleo,et al.  Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems. , 2011, Toxicology and applied pharmacology.

[31]  Victoria M Hitchins,et al.  Uptake of gold nanoparticles in murine macrophage cells without cytotoxicity or production of pro-inflammatory mediators , 2011, Nanotoxicology.

[32]  W. Chang,et al.  Fluorescent gold nanoclusters as a biocompatible marker for in vitro and in vivo tracking of endothelial cells. , 2011, ACS nano.

[33]  A. Roy,et al.  Mitochondria-Dependent Reactive Oxygen Species-Mediated Programmed Cell Death Induced by 3,3′-Diindolylmethane through Inhibition of F0F1-ATP Synthase in Unicellular Protozoan Parasite Leishmania donovani , 2008, Molecular Pharmacology.

[34]  Mingyuan Gao,et al.  Surface engineering of gold nanoparticles for in vitro siRNA delivery. , 2012, Nanoscale.

[35]  Francesco Stellacci,et al.  Effect of surface properties on nanoparticle-cell interactions. , 2010, Small.

[36]  S. Maiti,et al.  Molecular Effects of Uptake of Gold Nanoparticles in HeLa Cells , 2007, Chembiochem : a European journal of chemical biology.

[37]  Chun Xing Li,et al.  Pharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheres , 2014, Particle and Fibre Toxicology.

[38]  T. Decker,et al.  The regulation of inflammation by interferons and their STATs , 2013, JAK-STAT.

[39]  C. Murphy,et al.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.

[40]  Maria Dusinska,et al.  Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests , 2015, Nanotoxicology.

[41]  Mary Gulumian,et al.  Label-free in vitro toxicity and uptake assessment of citrate stabilised gold nanoparticles in three cell lines , 2013, Particle and Fibre Toxicology.

[42]  Patries M Herst,et al.  Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. , 2005, Biotechnology annual review.

[43]  Rodney A. Hill,et al.  Gold nanoparticles: the importance of physiological principles to devise strategies for targeted drug delivery. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[44]  G. Roam,et al.  Extensive evaluations of the cytotoxic effects of gold nanoparticles. , 2013, Biochimica et biophysica acta.

[45]  E. Wang,et al.  Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle , 2013, Proceedings of the National Academy of Sciences.

[46]  M. Abdelhalim.  Gold nanoparticles administration induces disarray of heart muscle, hemorrhagic, chronic inflammatory cells infiltrated by small lymphocytes, cytoplasmic vacuolization and congested and dilated blood vessels , 2011, Lipids in Health and Disease.

[47]  Yi-Hui Lee,et al.  Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines. , 2014, Journal of hazardous materials.

[48]  Lev Dykman,et al.  Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. , 2011, Chemical Society reviews.